Literature DB >> 8524236

Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells.

V Krishnan1, W Porter, M Santostefano, X Wang, S Safe.   

Abstract

17 beta-Estradiol (E2) induces cathepsin D mRNA levels and intracellular levels of immunoreactive protein in MCF-7 human breast cancer cells. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alone does not affect cathepsin D gene expression in this cell line; however, in cells cotreated with TCDD and E2, TCDD inhibited E2-induced cathepsin D mRNA levels, the rate of gene transcription, and levels of immunoreactive protein. The inhibitory responses were observed within 30 to 120 min after the cells were treated with TCDD. TCDD also inhibited E2-induced secreted alkaline phosphatase activity in aryl hydrocarbon (Ah)-responsive MCF-7 and wild-type mouse Hepa 1c1c7 cells cotransfected with the human estrogen receptor (hER) and the pBC12/S1/pac plasmid, which contains the 5' promoter region (-296/+57) of the cathepsin D gene and an alkaline phosphatase reporter gene. The E2-responsive ER/Sp1 sequence (-199 to -165) in the cathepsin D 5' region contains an imperfect GTGCGTG (-175/-181) xenobiotic responsive element (XRE); the role of this sequence in Ah responsiveness was investigated in gel electrophoretic mobility shift assays and with plasmid constructs containing a wild-type ER/Sp1 oligonucleotide or a mutant ER/Sp1-"XRE" oligonucleotide containing two C-->A mutations in the XRE sequence (antisense strand). In plasmid constructs which contained a chloramphenicol acetyltransferase reporter gene and the wild-type ER/Sp1 promoter sequence, E2-induced chloramphenicol acetyltransferase activity and mRNA levels were inhibited by TCDD whereas no inhibition was observed with the mutant ER/Sp1-"XRE" plasmids. Electrophoretic mobility shift assays showed that the nuclear or transformed cytosolic Ah receptor complex blocked formation of the ER-Sp1 complex with the wild-type but not the ER/Sp1 mutant oligonucleotide. Moreover, incubation of the wild-type bromodeoxyuridine-substituted ER/Sp1 oligonucleotide with the nuclear Ah receptor complex gave a specifically bound cross-linked 200-kDa band. These data demonstrate that Ah receptor-mediated inhibition of E2-induced cathepsin D gene expression is due to disruption of the ER-Sp1 complex by targeted interaction with an overlapping XRE.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8524236      PMCID: PMC230924          DOI: 10.1128/MCB.15.12.6710

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  79 in total

1.  Effects of tamoxifen and 4-hydroxytamoxifen on the pNR-1 and pNR-2 estrogen-regulated RNAs in human breast cancer cells.

Authors:  F E May; B R Westley
Journal:  J Biol Chem       Date:  1987-11-25       Impact factor: 5.157

2.  The DNA recognition site for the dioxin-Ah receptor complex. Nucleotide sequence and functional analysis.

Authors:  M S Denison; J M Fisher; J P Whitlock
Journal:  J Biol Chem       Date:  1988-11-25       Impact factor: 5.157

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Effects of oestrogen and the antioestrogens, tamoxifen and LY117018, on four oestrogen-regulated RNAs in the EFM-19 breast cancer cell line.

Authors:  B R Westley; F Hölzel; F E May
Journal:  J Steroid Biochem       Date:  1989-03       Impact factor: 4.292

5.  Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells.

Authors:  J Berger; J Hauber; R Hauber; R Geiger; B R Cullen
Journal:  Gene       Date:  1988-06-15       Impact factor: 3.688

6.  Suppression of estrogen-regulated extracellular tissue plasminogen activator activity of MCF-7 cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  J F Gierthy; D W Lincoln; M B Gillespie; J I Seeger; H L Martinez; H W Dickerman; S A Kumar
Journal:  Cancer Res       Date:  1987-12-01       Impact factor: 12.701

7.  Ah receptor in human placenta: stabilization by molybdate and characterization of binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin, 3-methylcholanthrene, and benzo(a)pyrene.

Authors:  D K Manchester; S K Gordon; C L Golas; E A Roberts; A B Okey
Journal:  Cancer Res       Date:  1987-09-15       Impact factor: 12.701

8.  Association of the Ah receptor with the 90-kDa heat shock protein.

Authors:  G H Perdew
Journal:  J Biol Chem       Date:  1988-09-25       Impact factor: 5.157

9.  Estrogens and growth factors induce the mRNA of the 52K-pro-cathepsin-D secreted by breast cancer cells.

Authors:  V Cavailles; P Augereau; M Garcia; H Rochefort
Journal:  Nucleic Acids Res       Date:  1988-03-25       Impact factor: 16.971

10.  Inducible, receptor-dependent protein-DNA interactions at a dioxin-responsive transcriptional enhancer.

Authors:  M S Denison; J M Fisher; J P Whitlock
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

View more
  33 in total

1.  Aryl hydrocarbon receptor modulation of estrogen receptor α-mediated gene regulation by a multimeric chromatin complex involving the two receptors and the coregulator RIP140.

Authors:  Zeynep Madak-Erdogan; Benita S Katzenellenbogen
Journal:  Toxicol Sci       Date:  2011-11-09       Impact factor: 4.849

Review 2.  Endocrine disruptors and falling sperm counts: lessons learned or not!

Authors:  Stephen Safe
Journal:  Asian J Androl       Date:  2012-09-24       Impact factor: 3.285

Review 3.  Regulation of cytochrome P450 (CYP) genes by nuclear receptors.

Authors:  P Honkakoski; M Negishi
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

Review 4.  Endocrine disrupting chemicals targeting estrogen receptor signaling: identification and mechanisms of action.

Authors:  Erin K Shanle; Wei Xu
Journal:  Chem Res Toxicol       Date:  2010-11-05       Impact factor: 3.739

5.  Malignant transformation of mammary epithelial cells by ectopic overexpression of the aryl hydrocarbon receptor.

Authors:  J Brooks; S E Eltom
Journal:  Curr Cancer Drug Targets       Date:  2011-06       Impact factor: 3.428

Review 6.  Mechanisms of inhibitory aryl hydrocarbon receptor-estrogen receptor crosstalk in human breast cancer cells.

Authors:  S Safe; M Wormke; I Samudio
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-07       Impact factor: 2.673

7.  Activation of the aryl hydrocarbon receptor is essential for mediating the anti-inflammatory effects of a novel low-molecular-weight compound.

Authors:  B Paige Lawrence; Michael S Denison; Hermann Novak; Beth A Vorderstrasse; Nathalie Harrer; Wolfgang Neruda; Claudia Reichel; Maximilian Woisetschläger
Journal:  Blood       Date:  2008-02-12       Impact factor: 22.113

8.  E2-mediated cathepsin D (CTSD) activation involves looping of distal enhancer elements.

Authors:  Nancy Bretschneider; Sara Kangaspeska; Martin Seifert; George Reid; Frank Gannon; Stefanie Denger
Journal:  Mol Oncol       Date:  2008-05-29       Impact factor: 6.603

9.  The active form of human aryl hydrocarbon receptor (AHR) repressor lacks exon 8, and its Pro 185 and Ala 185 variants repress both AHR and hypoxia-inducible factor.

Authors:  Sibel I Karchner; Matthew J Jenny; Ann M Tarrant; Brad R Evans; Hyo Jin Kang; Insoo Bae; David H Sherr; Mark E Hahn
Journal:  Mol Cell Biol       Date:  2009-04-20       Impact factor: 4.272

Review 10.  Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target.

Authors:  Stephen Safe; Syng-Ook Lee; Un-Ho Jin
Journal:  Toxicol Sci       Date:  2013-06-14       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.